Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation

Artikel in diesem Heft

1. TABLE OF CONTENTS
2. EDITORIAL
3. Public Policy to Prevent Childhood Obesity, and the Role of Pediatric Endocrinologists
4. Growth Hormone in Cystic Fibrosis
5. Study of Glucose Profiles with Continuous Glucose Monitoring in Adolescents with Poorly Controlled Type 2 Diabetes Mellitus
6. Determinants of Plasma Adiponectin Levels in Obese Children
7. Evaluation of Diagnosis and Treatment Results in Children with Graves' Disease with Emphasis on the Pubertal Status of Patients
8. Differential Presentation for Children with Autoimmune Thyroiditis Discovered Because of Symptom Development or Screening
9. Effect of Inspiration/Expiration on Height Measurement
10. Body Image in Adolescents with Disorders of Steroidogenesis
11. Identification of Frequency and Distribution of the Nine Most Frequent Mutations among Patients with 21-Hydroxylase Deficiency in Turkey
12. Growth in Familial Mediterranean Fever: Effect of Attack Rate, Genotype and Colchicine Treatment
13. Growth Hormone Therapy Improves Growth in Children with Cystic Fibrosis Related Liver Disease
14. Isolated Adrenocorticotropic Hormone Deficiency Presenting as an Acute Neurologic Emergency in a Peripubertal Girl
15. Non-Islet-Cell Tumor Hypoglycemia and Lactic Acidosis in a Child with Congenital HIV and Burkitt's Lymphoma
16. Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation
17. CALENDAR